BECN1 and neoplasm: TGF-β1 pro-treatment in Star-treated NIH3T3 fibroblasts significantly enhanced the expression of BNIP3, Beclin 1 and LC3β-II/I conversion in the mixed xenograft tumor, while 3-MA suppressed the effects of TGF-β1 (Figure 7C).